On ECHEMI
Home > Drugs > Jiangxi Health Pharmaceutical Co., Ltd.
Jiangxi Health Pharmaceutical Co., Ltd.
  • Founded in:

    1999-05-04
  • Country:

    China China
  • Address:

    Yichun Yuanzhou Pharmaceutical Industrial Park
  • Tax NO.:

    913609001609615995
  • Registered Funds:

    91.25 million yuan
  • Website:

  • Email:

Related Drugs
Lithium carbonate tablets
The main ingredient of this product and its chemical name is: lithium carbonate.
Name Description Content CAS NO. Registered Holders
Lithium carbonate

This product works in the form of lithium ions. Its mechanism of preventing manic attacks is to inhibit the Ca2-dependent release of norepinephrine and dopamine from nerve endings, promote the reuptake of norepinephrine in the synaptic cleft by nerve cells, increase its conversion and inactivation, thereby reducing the concentration of norepinephrine. It can also promote the synthesis and release of serotonin, which helps stabilize mood.

More

This product works in the form of lithium ions. Its mechanism of preventing manic attacks is to inhibit the Ca2-dependent release of norepinephrine and dopamine from nerve endings, promote the reuptake of norepinephrine in the synaptic cleft by nerve cells, increase its conversion and inactivation, thereby reducing the concentration of norepinephrine. It can also promote the synthesis and release of serotonin, which helps stabilize mood.

554-13-2 25
Shengsanqi Powder
Panax notoginseng.
Name Description Content CAS NO. Registered Holders
NOTOGINSENG RADIX ET RHIZOMA

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

0
Nicorandil Tablets
The main ingredient of this product is Nicorandil, and its chemical name is: nicotinamide ethyl nitrate.
Name Description Content CAS NO. Registered Holders
Nicorandil

Anti-angina drug. This product belongs to the nitrate compound, which has the effect of preventing the free calcium ions in cells, increasing the permeability of cell membranes to potassium ions, dilating coronary blood vessels, continuously increasing coronary blood flow, and inhibiting coronary artery spasm. When dilating coronary blood vessels, it does not affect blood pressure, heart rate, myocardial contractility, and myocardial oxygen consumption. This product also has the effect of inhibiting platelet aggregation and preventing thrombosis.

More

Anti-angina drug. This product belongs to the nitrate compound, which has the effect of preventing the free calcium ions in cells, increasing the permeability of cell membranes to potassium ions, dilating coronary blood vessels, continuously increasing coronary blood flow, and inhibiting coronary artery spasm. When dilating coronary blood vessels, it does not affect blood pressure, heart rate, myocardial contractility, and myocardial oxygen consumption. This product also has the effect of inhibiting platelet aggregation and preventing thrombosis.

65141-46-0 33
Fenbufen Tablets
The main ingredient of this product is fenbufen (C16H14O3), whose chemical name is 3-(4-biphenylcarbonyl) propionic acid. Its structural formula is: Molecular formula: C16H14O3 Molecular weight: 254.28
Name Description Content CAS NO. Registered Holders
Fenbufen

This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin.

More

This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin.

36330-85-5 8
Fenbufen Tablets
The main ingredient of this product is fenbufen (C16H14O3), whose chemical name is 3-(4-biphenylcarbonyl) propionic acid. Its structural formula is: Molecular formula: C16H14O3 Molecular weight: 254.28
Name Description Content CAS NO. Registered Holders
Fenbufen

This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin.

More

This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin.

36330-85-5 8
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.